Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment By: MarketWatch December 08, 2023 at 12:03 PM EST Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr. Read More >> Related Stocks: Bluebird Bio Crispr Therapeutics Ag Editas Medicine Vertex Pharmaceuticals Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment By: MarketWatch December 08, 2023 at 12:03 PM EST Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr. Read More >> Related Stocks: Bluebird Bio Crispr Therapeutics Ag Editas Medicine Vertex Pharmaceuticals